董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Peter Tuxen Bisgaard | 男 | Director | 47 | 13.31万美元 | 未持股 | 2021-09-24 |
| Nina L. Richardson | 女 | Director | 62 | 18.09万美元 | 未持股 | 2021-09-24 |
| Christian Gormsen | 男 | President, Chief Executive Officer and Director | 45 | 381.17万美元 | 未持股 | 2021-09-24 |
| Josh Makower | 男 | Chairman and Director | 58 | 14.37万美元 | 未持股 | 2021-09-24 |
| Doug Hughes | 男 | Director | 60 | 18.15万美元 | 未持股 | 2021-09-24 |
| David Wu | 男 | Director | 53 | 13.00万美元 | 未持股 | 2021-09-24 |
| Katie Bayne | 女 | Director | 54 | 未披露 | 未持股 | 2021-09-24 |
| Brooke Seawell | 男 | Director | 73 | 18.40万美元 | 未持股 | 2021-09-24 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Christian Gormsen | 男 | President, Chief Executive Officer and Director | 45 | 381.17万美元 | 未持股 | 2021-09-24 |
| William Brownie | 男 | Chief Operating Officer | 54 | 128.99万美元 | 未持股 | 2021-09-24 |
| Adam Laponis | 男 | Chief Financial Officer | 45 | 139.67万美元 | 未持股 | 2021-09-24 |
董事简历
中英对照 | 中文 | 英文- Peter Tuxen Bisgaard
-
Peter Tuxen Bisgaard，他担任我们的董事（2015年以来）。2009年以来，他一直担任Novo Ventures US Inc（为Novo A/S提供咨询服务，丹麦有限责任公司，管理投资和金融资产）的合伙人。他是Ceterix Orthopaedics Inc.、Entasis Therapeutics Inc.、Outpost Medicine, LLC的董事会成员，以及HTG Molecular Diagnostics Inc的董事会主席。他于1998年获得the Technical University of Denmark的硕士学位，并同时获得the European Consortium for Mathematics in the Industry的数学建模的经济学研究生学位。
Peter Tuxen Bisgaard has served as a member of our Board since October 2017. Since September 2017 Mr. Bisgaard has been Managing Director of Nan Fung Life Sciences, a global life sciences investment platform and a Managing Partner at Pivotal Bioventure Partners LLC, a healthcare venture capital fund. Prior to this, he was a Senior Partner at Novo Ventures, a healthcare focused venture investment firm, from 2009 to September 2017. Prior to Novo Ventures he was with McKinsey and Co. He has previously served on the board of directors of the following publicly held companies: Ra Pharmaceuticals, Inc., a clinical stage biopharmaceutical company; Nevro Corp, a commercial stage medical device company; HTG Molecular Diagnostics, Inc., a commercial stage RNA-platform based life sciences tools company; Otonomy, Inc., a biopharmaceutical company developing therapeutics for treating hearing disorders; and Alder Biopharmaceuticals, Inc., a late stage drug development company focusing on migraine therapeutics. In addition, Mr. Bisgaard is serving, and has served, on numerous boards of privately held biotechnology and medical technology companies. Mr. Bisgaard received an M.Sc. in engineering from Technical University of Denmark and a post graduate degree in mathematical modeling in economics by the European Consortium for Mathematics in the Industry. - Peter Tuxen Bisgaard，他担任我们的董事（2015年以来）。2009年以来，他一直担任Novo Ventures US Inc（为Novo A/S提供咨询服务，丹麦有限责任公司，管理投资和金融资产）的合伙人。他是Ceterix Orthopaedics Inc.、Entasis Therapeutics Inc.、Outpost Medicine, LLC的董事会成员，以及HTG Molecular Diagnostics Inc的董事会主席。他于1998年获得the Technical University of Denmark的硕士学位，并同时获得the European Consortium for Mathematics in the Industry的数学建模的经济学研究生学位。
- Peter Tuxen Bisgaard has served as a member of our Board since October 2017. Since September 2017 Mr. Bisgaard has been Managing Director of Nan Fung Life Sciences, a global life sciences investment platform and a Managing Partner at Pivotal Bioventure Partners LLC, a healthcare venture capital fund. Prior to this, he was a Senior Partner at Novo Ventures, a healthcare focused venture investment firm, from 2009 to September 2017. Prior to Novo Ventures he was with McKinsey and Co. He has previously served on the board of directors of the following publicly held companies: Ra Pharmaceuticals, Inc., a clinical stage biopharmaceutical company; Nevro Corp, a commercial stage medical device company; HTG Molecular Diagnostics, Inc., a commercial stage RNA-platform based life sciences tools company; Otonomy, Inc., a biopharmaceutical company developing therapeutics for treating hearing disorders; and Alder Biopharmaceuticals, Inc., a late stage drug development company focusing on migraine therapeutics. In addition, Mr. Bisgaard is serving, and has served, on numerous boards of privately held biotechnology and medical technology companies. Mr. Bisgaard received an M.Sc. in engineering from Technical University of Denmark and a post graduate degree in mathematical modeling in economics by the European Consortium for Mathematics in the Industry.
- Nina L. Richardson
-
NinaL.Richardson担任Three Rivers Energy，Inc.（她于2004年共同创立的公司）的董事总经理，并自2015年3月起担任独立顾问。2013年2月至2015年2月，Richardson女士担任Gopro，Inc.首席运营官她还在Flextronics，Inc.（一家全球电子和制造服务提供商）担任多个职责递增的执行职位。Richardson女士在普渡大学（Purdue University）获得工业工程学士学位，并在佩珀代因大学（Pepperdine University）获得执行工商管理硕士学位。她是Zayo集团控股有限公司和Silicon LaboratoriesInc.的董事。她曾担任Callidus Software，Inc.的董事（2017年至2018年）和Silicon Graphics InternationalCorp.
Nina L. Richardson serves as managing director of Three Rivers Energy, Inc., a company she co-founded in 2004 and has been an independent consultant since March 2015. From February 2013 to February 2015 Ms. Richardson served as chief operating officer of GoPro, Inc. She has also held several executive positions of increasing responsibility at Flextronics, Inc., a global electronics and manufacturing service provider. Ms. Richardson received her B.S. degree in industrial engineering from Purdue University and an executive M.B.A. from Pepperdine University. She is a director at Zayo Group Holdings, Inc. and Silicon Laboratories Inc. She previously served as a director at Callidus Software, Inc. 2017-2018 and Silicon Graphics International Corp. - NinaL.Richardson担任Three Rivers Energy，Inc.（她于2004年共同创立的公司）的董事总经理，并自2015年3月起担任独立顾问。2013年2月至2015年2月，Richardson女士担任Gopro，Inc.首席运营官她还在Flextronics，Inc.（一家全球电子和制造服务提供商）担任多个职责递增的执行职位。Richardson女士在普渡大学（Purdue University）获得工业工程学士学位，并在佩珀代因大学（Pepperdine University）获得执行工商管理硕士学位。她是Zayo集团控股有限公司和Silicon LaboratoriesInc.的董事。她曾担任Callidus Software，Inc.的董事（2017年至2018年）和Silicon Graphics InternationalCorp.
- Nina L. Richardson serves as managing director of Three Rivers Energy, Inc., a company she co-founded in 2004 and has been an independent consultant since March 2015. From February 2013 to February 2015 Ms. Richardson served as chief operating officer of GoPro, Inc. She has also held several executive positions of increasing responsibility at Flextronics, Inc., a global electronics and manufacturing service provider. Ms. Richardson received her B.S. degree in industrial engineering from Purdue University and an executive M.B.A. from Pepperdine University. She is a director at Zayo Group Holdings, Inc. and Silicon Laboratories Inc. She previously served as a director at Callidus Software, Inc. 2017-2018 and Silicon Graphics International Corp.
- Christian Gormsen
-
Christian Gormsen自2014年11月起担任董事会成员，自2016年6月起担任总裁兼首席执行官。2014年6月至2016年6月，Gormsen先生担任ISS A/S（一家全球设施服务公司）的EMEA商业总监。在此之前，他在GN Group（包括助听器在内的智能音频解决方案的全球领导者）工作了十年，担任越来越重要的职务，直到他成为运营、欧洲和战略客户的高级副总裁。Gormsen先生在过渡到麦肯锡公司（McKinsey&Company）之前开始了他的投资银行职业生涯，这是一家管理咨询公司。Gormsen先生在哥本哈根商学院（Copenhagen Business School）获得经济学学士学位和经济学与工商管理硕士学位。
Christian Gormsen has served as a member of our Board since November 2014 and as our President and Chief Executive Officer since June 2016. From June 2014 to June 2016 Mr. Gormsen served as Commercial Director, EMEA, of ISS A/S, a global facility services company. Prior to that, he spent a decade at GN Group, a global leader in intelligent audio solutions including hearing aids, in roles of increasing responsibility until he became the Senior Vice President of Operations, Europe and Strategic Accounts. Mr. Gormsen started his career in investment banking before transitioning to McKinsey & Company, a management consulting firm. Mr. Gormsen received a B.S. in economics and his M.S. in economics and business administration from the Copenhagen Business School. - Christian Gormsen自2014年11月起担任董事会成员，自2016年6月起担任总裁兼首席执行官。2014年6月至2016年6月，Gormsen先生担任ISS A/S（一家全球设施服务公司）的EMEA商业总监。在此之前，他在GN Group（包括助听器在内的智能音频解决方案的全球领导者）工作了十年，担任越来越重要的职务，直到他成为运营、欧洲和战略客户的高级副总裁。Gormsen先生在过渡到麦肯锡公司（McKinsey&Company）之前开始了他的投资银行职业生涯，这是一家管理咨询公司。Gormsen先生在哥本哈根商学院（Copenhagen Business School）获得经济学学士学位和经济学与工商管理硕士学位。
- Christian Gormsen has served as a member of our Board since November 2014 and as our President and Chief Executive Officer since June 2016. From June 2014 to June 2016 Mr. Gormsen served as Commercial Director, EMEA, of ISS A/S, a global facility services company. Prior to that, he spent a decade at GN Group, a global leader in intelligent audio solutions including hearing aids, in roles of increasing responsibility until he became the Senior Vice President of Operations, Europe and Strategic Accounts. Mr. Gormsen started his career in investment banking before transitioning to McKinsey & Company, a management consulting firm. Mr. Gormsen received a B.S. in economics and his M.S. in economics and business administration from the Copenhagen Business School.
- Josh Makower
-
Josh Makower自2018年12月起担任董事会非执行主席，自2015年11月起担任董事会成员。Makower自2015年5月起担任New Enterprise Associates（一家风险投资公司）普通合伙人。除了在New Enterprise Associates任职外，Makower博士还担任斯坦福大学医学院（Stanford University Medical School）的医学兼职教授，并是斯坦福大学（Stanford University）生物设计创新计划的联合创始人。Makower博士也是ExploraMed公司（一家医疗设备孵化器）的创始人兼执行主席。他在麻省理工学院（Massachusetts Institute of Technology）获得机械工程学士学位，在纽约大学医学院（New York University School of Medicine）获得医学博士学位，在哥伦比亚大学（Columbia University）获得工商管理硕士学位。
Josh Makower has served as the non-executive Chairman of our Board since December 2018 and as a member of our Board since November 2015. From May 2015 until August 2021 Dr. Makower was a General Partner at New Enterprise Associates, a venture capital firm; as of August 1 2021 Dr. Makower is a Special Partner. In addition to his role at New Enterprise Associates, Dr. Makower serves as a Professor of Medicine at Stanford University Medical School and is Co-Founder of Stanford University’s Biodesign Innovation Program. Dr. Makower is also the Founder and Executive Chairman of ExploraMed, a medical device incubator. He received a B.S. in mechanical engineering from Massachusetts Institute of Technology, his M.D. from New York University School of Medicine and his M.B.A. from Columbia University. - Josh Makower自2018年12月起担任董事会非执行主席，自2015年11月起担任董事会成员。Makower自2015年5月起担任New Enterprise Associates（一家风险投资公司）普通合伙人。除了在New Enterprise Associates任职外，Makower博士还担任斯坦福大学医学院（Stanford University Medical School）的医学兼职教授，并是斯坦福大学（Stanford University）生物设计创新计划的联合创始人。Makower博士也是ExploraMed公司（一家医疗设备孵化器）的创始人兼执行主席。他在麻省理工学院（Massachusetts Institute of Technology）获得机械工程学士学位，在纽约大学医学院（New York University School of Medicine）获得医学博士学位，在哥伦比亚大学（Columbia University）获得工商管理硕士学位。
- Josh Makower has served as the non-executive Chairman of our Board since December 2018 and as a member of our Board since November 2015. From May 2015 until August 2021 Dr. Makower was a General Partner at New Enterprise Associates, a venture capital firm; as of August 1 2021 Dr. Makower is a Special Partner. In addition to his role at New Enterprise Associates, Dr. Makower serves as a Professor of Medicine at Stanford University Medical School and is Co-Founder of Stanford University’s Biodesign Innovation Program. Dr. Makower is also the Founder and Executive Chairman of ExploraMed, a medical device incubator. He received a B.S. in mechanical engineering from Massachusetts Institute of Technology, his M.D. from New York University School of Medicine and his M.B.A. from Columbia University.
- Doug Hughes
-
Doug Hughes自2020年9月起担任我们的董事会成员。自2019年10月起，休斯先生担任泌尿外科医疗器械公司Calyxo，Inc.的首席财务官。从2011年到2018年4月，休斯先生担任泌尿外科公司Neotract，Inc.的首席财务官。他曾担任Nellix公司（血管内移植公司）的首席财务官兼首席运营官（从2010年到2011年）。在加入Nellix公司之前，Hughes先生从2009年到2010年担任Evalve公司（一家心血管公司）的首席财务官。2009年之前，Hughes先生曾在Boston Scientific、Guidant Corporation和高乐氏公司担任多个高级财务管理职位。休斯先生目前是上市生物制药公司Immunovant，Inc.的董事会成员。Hughes先生在旧金山州立大学（San Francisco State University）获得金融学学士学位，并在芝加哥大学（University of Chicago）获得工商管理硕士学位。
Doug Hughes has served as a member of our Board since September 2020. Since October 2019 Mr. Hughes has served as Chief Financial Officer of Calyxo, Inc., a urology medical device company. From 2011 until April 2018 Mr. Hughes was Chief Financial Officer of NeoTract, Inc., a urology company. He served as Chief Financial Officer and Chief Operating Officer for Nellix, Inc., an endovascular graft company from 2010 until 2011. Before joining Nellix, Inc., Mr. Hughes served as Chief Financial Officer for Evalve Inc., a cardiovascular company, from 2009 until 2010. Prior to 2009 Mr. Hughes held a variety of senior finance management positions at Boston Scientific, Guidant Corporation and The Clorox Company. Mr. Hughes is currently a member of the board of directors of Immunovant, Inc., a publicly held biopharmaceutical company. Mr. Hughes received a B.S. in finance from San Francisco State University and his M.B.A. from University of Chicago. - Doug Hughes自2020年9月起担任我们的董事会成员。自2019年10月起，休斯先生担任泌尿外科医疗器械公司Calyxo，Inc.的首席财务官。从2011年到2018年4月，休斯先生担任泌尿外科公司Neotract，Inc.的首席财务官。他曾担任Nellix公司（血管内移植公司）的首席财务官兼首席运营官（从2010年到2011年）。在加入Nellix公司之前，Hughes先生从2009年到2010年担任Evalve公司（一家心血管公司）的首席财务官。2009年之前，Hughes先生曾在Boston Scientific、Guidant Corporation和高乐氏公司担任多个高级财务管理职位。休斯先生目前是上市生物制药公司Immunovant，Inc.的董事会成员。Hughes先生在旧金山州立大学（San Francisco State University）获得金融学学士学位，并在芝加哥大学（University of Chicago）获得工商管理硕士学位。
- Doug Hughes has served as a member of our Board since September 2020. Since October 2019 Mr. Hughes has served as Chief Financial Officer of Calyxo, Inc., a urology medical device company. From 2011 until April 2018 Mr. Hughes was Chief Financial Officer of NeoTract, Inc., a urology company. He served as Chief Financial Officer and Chief Operating Officer for Nellix, Inc., an endovascular graft company from 2010 until 2011. Before joining Nellix, Inc., Mr. Hughes served as Chief Financial Officer for Evalve Inc., a cardiovascular company, from 2009 until 2010. Prior to 2009 Mr. Hughes held a variety of senior finance management positions at Boston Scientific, Guidant Corporation and The Clorox Company. Mr. Hughes is currently a member of the board of directors of Immunovant, Inc., a publicly held biopharmaceutical company. Mr. Hughes received a B.S. in finance from San Francisco State University and his M.B.A. from University of Chicago.
- David Wu
-
David Wu，2014年7月起，担任本公司董事。自2012年以来，吴先生一直担任Maveron LLC（一家风险投资公司）的合伙人。Wu先生在斯坦福大学（Stanford University）获得电气工程与数量经济学的B.S.和B.A.。
David Wu has served as a member of our Board since July 2014. Since 2012 Mr. Wu has been a Partner at Maveron LLC, a venture capital firm, where his primary focus is emerging consumer Internet companies. Mr. Wu led Maveron’s investments in Illumix, inkbox, Booster, Wave and Eargo, and serves on each company’s board of directors. Mr. Wu received a B.S. in electrical engineering and a B.A. in quantitative economics from Stanford University. - David Wu，2014年7月起，担任本公司董事。自2012年以来，吴先生一直担任Maveron LLC（一家风险投资公司）的合伙人。Wu先生在斯坦福大学（Stanford University）获得电气工程与数量经济学的B.S.和B.A.。
- David Wu has served as a member of our Board since July 2014. Since 2012 Mr. Wu has been a Partner at Maveron LLC, a venture capital firm, where his primary focus is emerging consumer Internet companies. Mr. Wu led Maveron’s investments in Illumix, inkbox, Booster, Wave and Eargo, and serves on each company’s board of directors. Mr. Wu received a B.S. in electrical engineering and a B.A. in quantitative economics from Stanford University.
- Katie Bayne
-
Katie Bayne自2018年10月起担任我们的董事会成员。自2019年2月以来，Bayne女士一直担任Guggenheim Partners投资银行和资本市场部门Guggenheim Securities的高级顾问。自2018年3月起，Bayne女士还担任Bayne Advisors的创始人兼总裁，这是一家咨询公司，帮助品牌和企业找到其战略身份，推动持续的消费者参与并创新以实现转型成果。在担任现任职务之前，贝恩曾于1989年至2018年在TheCoca-ColaCompany担任多个职务，专注于美国、澳大利亚和全球的消费者战略、零售营销和消费者营销，最近担任该公司北美品牌总裁，2013年至2015年，高级副总裁，全球中心，2015年至2018年。Bayne女士曾担任Ascena RetailGroup，Inc.公司、AnnInc.公司和Beazer Homes USA公司的董事会成员。Bayne女士目前担任Acreage Holdings，Inc.（一家上市公司）的董事会成员。Bayne女士也是美国电影学院（American Film Institute）和杜克大学（Duke University）福夸商学院（Fuqua School of Business）的董事会成员。Bayne女士拥有Duke University心理学学士学位和Duke University’；S Fuqua School of Business工商管理硕士学位。
Katie Bayne has served as a member of our Board since June 2021. Since February 2019 Ms. Katie Bayne has served as a Senior Advisor with Guggenheim Securities, LLC, the investment banking and capital markets division of Guggenheim Partners. Since March 2018 Ms. Bayne has also served as founder and President of Bayne Advisors, a strategic and advisory firm. Prior to serving in her current roles, from 1989 to 2018 Ms. Bayne served in numerous roles at The Coca-Cola Company focused on general management, strategy, retail and consumer marketing in the United States, Australia and globally, including President, North America Brands and Chief Marketing Officer, North America. Ms. Bayne previously served as a member of the board of directors for Ascena Retail Group, Inc., Ann Inc. and Beazer Homes USA. - Katie Bayne自2018年10月起担任我们的董事会成员。自2019年2月以来，Bayne女士一直担任Guggenheim Partners投资银行和资本市场部门Guggenheim Securities的高级顾问。自2018年3月起，Bayne女士还担任Bayne Advisors的创始人兼总裁，这是一家咨询公司，帮助品牌和企业找到其战略身份，推动持续的消费者参与并创新以实现转型成果。在担任现任职务之前，贝恩曾于1989年至2018年在TheCoca-ColaCompany担任多个职务，专注于美国、澳大利亚和全球的消费者战略、零售营销和消费者营销，最近担任该公司北美品牌总裁，2013年至2015年，高级副总裁，全球中心，2015年至2018年。Bayne女士曾担任Ascena RetailGroup，Inc.公司、AnnInc.公司和Beazer Homes USA公司的董事会成员。Bayne女士目前担任Acreage Holdings，Inc.（一家上市公司）的董事会成员。Bayne女士也是美国电影学院（American Film Institute）和杜克大学（Duke University）福夸商学院（Fuqua School of Business）的董事会成员。Bayne女士拥有Duke University心理学学士学位和Duke University’；S Fuqua School of Business工商管理硕士学位。
- Katie Bayne has served as a member of our Board since June 2021. Since February 2019 Ms. Katie Bayne has served as a Senior Advisor with Guggenheim Securities, LLC, the investment banking and capital markets division of Guggenheim Partners. Since March 2018 Ms. Bayne has also served as founder and President of Bayne Advisors, a strategic and advisory firm. Prior to serving in her current roles, from 1989 to 2018 Ms. Bayne served in numerous roles at The Coca-Cola Company focused on general management, strategy, retail and consumer marketing in the United States, Australia and globally, including President, North America Brands and Chief Marketing Officer, North America. Ms. Bayne previously served as a member of the board of directors for Ascena Retail Group, Inc., Ann Inc. and Beazer Homes USA.
- Brooke Seawell
-
Brooke Seawell 自2011年11月起，他一直担任我们的董事会成员。自2005年1月起 ，他一直是New Enterprise Associates公司（NEA ）的投资合伙人。在加入NEA之前，2000年2月至2004年12月，他在科技交叉合伙风险投资公司（一家风险投资公司）就职。1997年至1998年，他还担任NetDynamics公司的执行副总裁，一家被Sun微系统公司收购了的应用服务器软件的公司；1991年至1997年，担任Synopsys公司财务和运营的高级副总裁及财务总监，这是一家电子设计自动化软件公司。1983年至1991年，他曾担任Weitek公司财务及生产的副总裁、财务总监，这是一家无晶圆厂半导体公司；1979年至1983年，担任韶华科技公司的共同创办人兼首席财务总监，这是一家复杂的薄膜涂料公司。他目前担任NVIDIA公司，Informatica公司和各民营科技企业的董事会成员。他也是斯坦福大学运动委员会的成员，曾任斯坦福大学商学院管理委员会成员。
Brooke Seawell has served as a member of our Board since September 2020. Since 2005 Mr. Seawell has been a Venture Partner at New Enterprise Associates. He was a Partner from 2000 to 2005 at Technology Crossover Ventures, a venture capital firm. From 1997 to 1998 he was Executive Vice President at NetDynamics, Inc., an application server software company, which was acquired by Sun Microsystems, Inc. From 1991 to 1997 he was Senior Vice President and Chief Financial Officer of Synopsys, Inc., an electronic design automation software company. Mr. Seawell serves on the boards of the following publicly held companies: NVIDIA Corporation, an accelerated computing company, where he serves on the audit committee, and Tenable Holdings, Inc., a cyber exposure solutions company, where he serves on the audit committee. Mr. Seawell previously served on the board of directors of the following publicly held companies: Tableau Software, Inc., a business intelligence software company; Informatica Corp., a data integration software company; and Glu Mobile, Inc., a publisher of mobile games. Mr. Seawell previously served on the Stanford University Athletic Board and the Management Board of the Stanford Graduate School of Business. Mr. Seawell received a B.A. degree in economics and his M.B.A. in Finance from Stanford University. - Brooke Seawell 自2011年11月起，他一直担任我们的董事会成员。自2005年1月起 ，他一直是New Enterprise Associates公司（NEA ）的投资合伙人。在加入NEA之前，2000年2月至2004年12月，他在科技交叉合伙风险投资公司（一家风险投资公司）就职。1997年至1998年，他还担任NetDynamics公司的执行副总裁，一家被Sun微系统公司收购了的应用服务器软件的公司；1991年至1997年，担任Synopsys公司财务和运营的高级副总裁及财务总监，这是一家电子设计自动化软件公司。1983年至1991年，他曾担任Weitek公司财务及生产的副总裁、财务总监，这是一家无晶圆厂半导体公司；1979年至1983年，担任韶华科技公司的共同创办人兼首席财务总监，这是一家复杂的薄膜涂料公司。他目前担任NVIDIA公司，Informatica公司和各民营科技企业的董事会成员。他也是斯坦福大学运动委员会的成员，曾任斯坦福大学商学院管理委员会成员。
- Brooke Seawell has served as a member of our Board since September 2020. Since 2005 Mr. Seawell has been a Venture Partner at New Enterprise Associates. He was a Partner from 2000 to 2005 at Technology Crossover Ventures, a venture capital firm. From 1997 to 1998 he was Executive Vice President at NetDynamics, Inc., an application server software company, which was acquired by Sun Microsystems, Inc. From 1991 to 1997 he was Senior Vice President and Chief Financial Officer of Synopsys, Inc., an electronic design automation software company. Mr. Seawell serves on the boards of the following publicly held companies: NVIDIA Corporation, an accelerated computing company, where he serves on the audit committee, and Tenable Holdings, Inc., a cyber exposure solutions company, where he serves on the audit committee. Mr. Seawell previously served on the board of directors of the following publicly held companies: Tableau Software, Inc., a business intelligence software company; Informatica Corp., a data integration software company; and Glu Mobile, Inc., a publisher of mobile games. Mr. Seawell previously served on the Stanford University Athletic Board and the Management Board of the Stanford Graduate School of Business. Mr. Seawell received a B.A. degree in economics and his M.B.A. in Finance from Stanford University.
高管简历
中英对照 | 中文 | 英文- Christian Gormsen
Christian Gormsen自2014年11月起担任董事会成员，自2016年6月起担任总裁兼首席执行官。2014年6月至2016年6月，Gormsen先生担任ISS A/S（一家全球设施服务公司）的EMEA商业总监。在此之前，他在GN Group（包括助听器在内的智能音频解决方案的全球领导者）工作了十年，担任越来越重要的职务，直到他成为运营、欧洲和战略客户的高级副总裁。Gormsen先生在过渡到麦肯锡公司（McKinsey&Company）之前开始了他的投资银行职业生涯，这是一家管理咨询公司。Gormsen先生在哥本哈根商学院（Copenhagen Business School）获得经济学学士学位和经济学与工商管理硕士学位。
Christian Gormsen has served as a member of our Board since November 2014 and as our President and Chief Executive Officer since June 2016. From June 2014 to June 2016 Mr. Gormsen served as Commercial Director, EMEA, of ISS A/S, a global facility services company. Prior to that, he spent a decade at GN Group, a global leader in intelligent audio solutions including hearing aids, in roles of increasing responsibility until he became the Senior Vice President of Operations, Europe and Strategic Accounts. Mr. Gormsen started his career in investment banking before transitioning to McKinsey & Company, a management consulting firm. Mr. Gormsen received a B.S. in economics and his M.S. in economics and business administration from the Copenhagen Business School.- Christian Gormsen自2014年11月起担任董事会成员，自2016年6月起担任总裁兼首席执行官。2014年6月至2016年6月，Gormsen先生担任ISS A/S（一家全球设施服务公司）的EMEA商业总监。在此之前，他在GN Group（包括助听器在内的智能音频解决方案的全球领导者）工作了十年，担任越来越重要的职务，直到他成为运营、欧洲和战略客户的高级副总裁。Gormsen先生在过渡到麦肯锡公司（McKinsey&Company）之前开始了他的投资银行职业生涯，这是一家管理咨询公司。Gormsen先生在哥本哈根商学院（Copenhagen Business School）获得经济学学士学位和经济学与工商管理硕士学位。
- Christian Gormsen has served as a member of our Board since November 2014 and as our President and Chief Executive Officer since June 2016. From June 2014 to June 2016 Mr. Gormsen served as Commercial Director, EMEA, of ISS A/S, a global facility services company. Prior to that, he spent a decade at GN Group, a global leader in intelligent audio solutions including hearing aids, in roles of increasing responsibility until he became the Senior Vice President of Operations, Europe and Strategic Accounts. Mr. Gormsen started his career in investment banking before transitioning to McKinsey & Company, a management consulting firm. Mr. Gormsen received a B.S. in economics and his M.S. in economics and business administration from the Copenhagen Business School.
- William Brownie
William Brownie自2019年4月起担任我们的首席运营官。从2016年8月至2019年3月，Brownie先生担任我们的首席客户运营官。此外，2017年1月至2019年6月，他担任我们的首席财务官。2015年6月至2016年8月，Brownie先生担任多家公司的独立顾问。Brownie从2012年1月到2015年6月担任Sonova E-Hearing Care（Sonova AG一家集团公司）总经理。在此之前，从2001年8月到2011年12月，Brownie先生担任HearingPlanet Inc.的首席财务官，然后担任总裁兼首席执行官，该公司被Sonova AG收购。Brownie先生在圣地亚哥州立大学（San Diego State University-California State University）获得工商管理学士学位。
William Brownie has served as our Chief Operating Officer since April 2019. From August 2016 through March 2019 Mr. Brownie served as our Chief Customer Operations Officer. In addition, from January 2017 to June 2019 he served as our Chief Financial Officer. From June 2015 to August 2016 Mr. Brownie served as an independent consultant to various companies. From January 2012 to June 2015 Mr. Brownie served as the Managing Director at Sonova e-Hearing Care, a group company of Sonova AG. Prior to that, from August 2001 to December 2011 Mr. Brownie served as Chief Financial Officer and then President and Chief Executive Officer of HearingPlanet Inc., which was purchased by Sonova AG. Mr. Brownie received a B.S. in business administration from San Diego State University-California State University.- William Brownie自2019年4月起担任我们的首席运营官。从2016年8月至2019年3月，Brownie先生担任我们的首席客户运营官。此外，2017年1月至2019年6月，他担任我们的首席财务官。2015年6月至2016年8月，Brownie先生担任多家公司的独立顾问。Brownie从2012年1月到2015年6月担任Sonova E-Hearing Care（Sonova AG一家集团公司）总经理。在此之前，从2001年8月到2011年12月，Brownie先生担任HearingPlanet Inc.的首席财务官，然后担任总裁兼首席执行官，该公司被Sonova AG收购。Brownie先生在圣地亚哥州立大学（San Diego State University-California State University）获得工商管理学士学位。
- William Brownie has served as our Chief Operating Officer since April 2019. From August 2016 through March 2019 Mr. Brownie served as our Chief Customer Operations Officer. In addition, from January 2017 to June 2019 he served as our Chief Financial Officer. From June 2015 to August 2016 Mr. Brownie served as an independent consultant to various companies. From January 2012 to June 2015 Mr. Brownie served as the Managing Director at Sonova e-Hearing Care, a group company of Sonova AG. Prior to that, from August 2001 to December 2011 Mr. Brownie served as Chief Financial Officer and then President and Chief Executive Officer of HearingPlanet Inc., which was purchased by Sonova AG. Mr. Brownie received a B.S. in business administration from San Diego State University-California State University.
- Adam Laponis
Adam Laponis自2019年6月起担任我们的首席财务官。2018年11月至2019年3月，拉波尼斯先生担任汽车和能源公司特斯拉公司财务规划和分析Vice President，此前曾于2017年4月至2018年11月担任该公司高级财务总监。在此之前，他于2015年10月至2017年4月担任梦百合服务和产品公司Cardinal Health心血管护理Vice President兼首席财务官。在此之前，他曾于2004年8月至2015年10月在梦百合公司强生公司担任多个财务职位。LaBonis先生在加州大学伯克利分校（University of California，Berkeley）获得化学工程学士学位，并在南加州大学（University of Southern California）获得工商管理硕士学位。
Adam Laponis has served as our Chief Financial Officer since June 2019. From November 2018 to March 2019 Mr. Laponis served as Vice President of Financial Planning and Analysis for Tesla, an automotive and energy company, where he previously served as Senior Director of Finance from April 2017 to November 2018. Prior to that, he served as the Vice President and Chief Financial Officer of Cardiovascular Care of Cardinal Health, a healthcare services and products company, from October 2015 to April 2017. Prior to that, he served in various financial roles at Johnson & Johnson, a healthcare company, from August 2004 to October 2015. Mr. Laponis received a B.S. in chemical engineering from the University of California, Berkeley and his M.B.A. from the University of Southern California.- Adam Laponis自2019年6月起担任我们的首席财务官。2018年11月至2019年3月，拉波尼斯先生担任汽车和能源公司特斯拉公司财务规划和分析Vice President，此前曾于2017年4月至2018年11月担任该公司高级财务总监。在此之前，他于2015年10月至2017年4月担任梦百合服务和产品公司Cardinal Health心血管护理Vice President兼首席财务官。在此之前，他曾于2004年8月至2015年10月在梦百合公司强生公司担任多个财务职位。LaBonis先生在加州大学伯克利分校（University of California，Berkeley）获得化学工程学士学位，并在南加州大学（University of Southern California）获得工商管理硕士学位。
- Adam Laponis has served as our Chief Financial Officer since June 2019. From November 2018 to March 2019 Mr. Laponis served as Vice President of Financial Planning and Analysis for Tesla, an automotive and energy company, where he previously served as Senior Director of Finance from April 2017 to November 2018. Prior to that, he served as the Vice President and Chief Financial Officer of Cardiovascular Care of Cardinal Health, a healthcare services and products company, from October 2015 to April 2017. Prior to that, he served in various financial roles at Johnson & Johnson, a healthcare company, from August 2004 to October 2015. Mr. Laponis received a B.S. in chemical engineering from the University of California, Berkeley and his M.B.A. from the University of Southern California.